CMB Wealth Management's Zhaorui and Ding USD Closed-End Fund No. 407 Fixed Income Product will be launched on April 3. The performance benchmark for Share Class A is 3.3%–3.6%.

LightningPacketLoss · 2026-04-05T09:50:27+00:00

CMB Wealth Management recently announced the Zhaorui and Ding USD Closed-End 407 Fixed Income Investment Plan. The subscription period is from April 3 to April 9, 2026. The minimum subscription amount for Share Class A is $1. The product size ranges from $5 million to $50 million, with an expected duration of 183 days. The performance benchmark is an annualized return of 3.30% to 3.60%. Investment involves risks.

LightningPacketLoss

2026-04-05 09:50:27

Abstract generation in progress

On April 3, according to a disclosure by CMB Wealth Management, the subscription period for the Zhaorui and Ding USD Closed-End No. 407 fixed-income wealth management product issued by the company is from April 3, 2026 to April 9, 2026. The initial subscription amount for Class A shares is 1 USD. The product’s total issuance size has a minimum of USD 5 million and a maximum of USD 50 million. The product type is fixed-income. Its risk-return rating is PR1, indicating low risk. The expected term is 183 days. The performance benchmark for Class A shares is 3.30%-3.60% (annualized).

Note: The performance benchmark is not an expected rate of return. It does not indicate the product’s future performance or actual returns, and it does not constitute a commitment to the product’s returns.

The above information about the wealth management products is for reference only. For details, please refer to sales documents such as the Product Prospectus. This article does not constitute any investment advice. Investors act at their own risk.

(CMB Wealth Management)

(Editor: Qian Xiaorui)

Keywords:

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes